Amar Laurence
Rev Prat. 2015 Jun;65(6):817-21.
Primary aldosteronism affects 6% of hypertensive patients. The diagnosis should be suspected in any patient with severe or resistant hypertension or hypertension associated with hypokalemia. The screening test consists on the assessment of the aldosterone to renin ratio. In case of an elevated ratio, the diagnosis of primary aldosteronism is confirmed by either elevated concentrations of basal plasma and/or urinary aldosterone or absence of suppression of aldosterone during dynamic test (including the saline infusion test). CT aims to ensure the absence of adrenal carcinoma and to study the morphology of the adrenals. The unilateral or bilateral type of aldosterone secretion is based on the realization of an adrenal venous sampling. When the hypersecretion is unilateral, the treatment consists of adrenalectomy leading to cure of hypertension in 42% of cases, improvement in 40% of cases. For patient with bilateral disease or who don't want to undergo surgery, treatment is based on spironolactone usually at doses of 25 or 50 mg in combination with other antihypertensives drugs such as diuretics or calcium channel blockers.
原发性醛固酮增多症影响6%的高血压患者。对于任何患有重度或顽固性高血压或伴有低钾血症的高血压患者,均应怀疑该诊断。筛查试验包括评估醛固酮与肾素比值。如果该比值升高,原发性醛固酮增多症的诊断可通过基础血浆和/或尿醛固酮浓度升高或动态试验(包括生理盐水输注试验)期间醛固酮未被抑制来证实。CT旨在确保无肾上腺皮质癌并研究肾上腺形态。醛固酮分泌的单侧或双侧类型基于肾上腺静脉采血的结果。当分泌过多为单侧时,治疗包括肾上腺切除术,42%的病例可治愈高血压,40%的病例病情改善。对于双侧疾病患者或不愿接受手术的患者,治疗基于螺内酯,通常剂量为25或50毫克,并与其他抗高血压药物如利尿剂或钙通道阻滞剂联合使用。